𝕏xSE first seen 2 d ago, last 2 d ago, peak #32
Isomorphic Labs Seeks $40-50 Billion Valuation in Funding Talks
Original: Isomorphic Labs Eyes $40-50 Billion Valuation in New Funding Talks
Isomorphic Labs, the Alphabet-owned drug discovery company spun out of DeepMind, is reportedly in talks to raise new funding at a valuation of $40-50 billion. The company uses AI models, building on AlphaFold, to design new medicines and accelerate drug development. A round at that scale would place it among the most valuable AI-focused biotech firms, underscoring investor appetite for AI-driven pharmaceutical research.
Why now: Reports of a potential $40-50 billion valuation highlight surging investor interest in AI-powered drug discovery.
Isomorphic LabsAlphabetDeepMind
Rank over time, top of the chart is #1. 2 snapshots from 2 d ago to 2 d ago.
API: https://socialmediatrends-api.osmike.com/v1/trends/1461316